ERBB2 and breast cancer: Specifically, siRNA/shRNA-mediated knockdown (KD) of NELF-A or NELF-E in breast cancer cell lines of different subtypes (ER+, HER2+, and triple-negative) led to reduced anchorage-independent growth in vitro (Fig. 1b, c and Supplementary Fig. 1b, c).